Met Life Investment Management, LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 10, 2024	BUY	$6.04 - $9.66 $38,142 - $61,002	6,315 Added 44.05%	20,652 $155,000
Q3 2022 Jun 14, 2023	BUY	$6.04 - $9.66 $124,738 - $199,498	20,652 New	20,652 $155,000
Q3 2022 Mar 22, 2023	BUY	$6.04 - $9.66 $38,142 - $61,002	6,315 Added 44.05%	20,652 $155,000
Q3 2022 Nov 14, 2022	BUY	$6.04 - $9.66 $38,142 - $61,002	6,315 Added 44.05%	20,652 $156,000
Q2 2022 May 10, 2024	SELL	$4.99 - $8.96 $27,519 - $49,414	-5,515 Reduced 27.78%	14,337 $90,000
Q2 2022 Jun 20, 2023	BUY	$4.99 - $8.96 $71,541 - $128,459	14,337 New	14,337 $90,000
Q2 2022 Mar 22, 2023	SELL	$4.99 - $8.96 $27,519 - $49,414	-5,515 Reduced 27.78%	14,337 $90,000
Q2 2022 Aug 11, 2022	SELL	$4.99 - $8.96 $27,519 - $49,414	-5,515 Reduced 27.78%	14,337 $90,000
Q1 2022 May 10, 2024	BUY	$3.84 - $9.74 $76,231 - $193,358	19,852 New	19,852 $164,000
Q1 2022 Jun 20, 2023	BUY	$3.84 - $9.74 $76,231 - $193,358	19,852 New	19,852 $164,000
Q1 2022 Mar 22, 2023	BUY	$3.84 - $9.74 $29,882 - $75,796	7,782 Added 64.47%	19,852 $164,000
Q1 2022 May 12, 2022	BUY	$3.84 - $9.74 $76,231 - $193,358	19,852 New	19,852 $165,000
Q1 2021 May 14, 2021	SELL	$8.44 - $12.66 $101,870 - $152,806	-12,070 Closed	0 $0
Q4 2020 Jun 22, 2023	BUY	$7.98 - $12.29 $96,318 - $148,340	12,070 New	12,070 $148,000
Q3 2020 Jun 26, 2023	BUY	$7.96 - $12.42 $96,077 - $149,909	12,070 New	12,070 $98,000
Q2 2020 May 24, 2024	BUY	$5.4 - $13.37 $65,178 - $161,375	12,070 New	12,070 $116 Million
Q2 2020 Jun 26, 2023	BUY	$5.4 - $13.37 $65,178 - $161,375	12,070 New	12,070 $115,000
Q2 2020 Mar 22, 2023	SELL	$5.4 - $13.37 $3,034 - $7,513	-562 Reduced 4.45%	12,070 $115,000
Q2 2020 Aug 14, 2020	BUY	$5.4 - $13.37 $65,178 - $161,375	12,070 New	12,070 $116,000
Q1 2020 May 15, 2020	SELL	$4.91 - $14.7 $62,023 - $185,690	-12,632 Closed	0 $0
Q4 2019 Jul 12, 2023	BUY	$9.77 - $15.66 $123,414 - $197,817	12,632 New	12,632 $188,000
Q3 2019 Jul 12, 2023	BUY	$9.59 - $12.0 $121,140 - $151,584	12,632 New	12,632 $129,000
Q3 2019 Mar 22, 2023	BUY	$9.59 - $12.0 $121,140 - $151,584	12,632 New	12,632 $129,000
Q3 2019 Nov 14, 2019	BUY	$9.59 - $12.0 $121,140 - $151,584	12,632 New	12,632 $129,000
Q2 2019 Jul 12, 2023	BUY	$9.54 - $14.96 $120,509 - $188,974	12,632 New	12,632 $134 Million

Others Institutions Holding EIGR

# of Institutions

Shares Held

748K

Call Options Held

Put Options Held

View Full List

About Eiger BioPharmaceuticals, Inc.

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

More about EIGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account